Cargando…
Improving patient-reported measures in oncology: a payer call to action
Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes the landscape of oncology PRMs and PR-PMs, id...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394208/ https://www.ncbi.nlm.nih.gov/pubmed/33103618 http://dx.doi.org/10.18553/jmcp.2020.20313 |
_version_ | 1785083318413295616 |
---|---|
author | Schmidt, Theresa Valuck, Tom Perkins, Brittany Riposo, Jacqlyn Patel, Palak Westrich, Kimberly Basch, Ethan McClellan, Mark |
author_facet | Schmidt, Theresa Valuck, Tom Perkins, Brittany Riposo, Jacqlyn Patel, Palak Westrich, Kimberly Basch, Ethan McClellan, Mark |
author_sort | Schmidt, Theresa |
collection | PubMed |
description | Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes the landscape of oncology PRMs and PR-PMs, identifies implementation barriers, and recommends solutions for public and private payers to accelerate the appropriate use of PRMs in oncology VBP programs. Our research used a multimethod approach that included a literature review, landscape scan, stakeholder interviews and survey, and a multistakeholder roundtable. The literature review and landscape scan found that limited oncology-specific PR-PMs are available and some are already used in VBP programs. Diverse stakeholder perspectives provided insight into filling current gaps in measurement and removing implementation barriers, such as limited relevance of existing PRMs and PR-PMs for oncology; methodological challenges; patient burden and survey fatigue; and provider burden from resource constraints, competing priorities, and insufficient incentives. Key recommendations include: (a) identify or develop meaningful measures that fill gaps, engaging patients throughout measure and program development and evaluation; (b) design programs that include scientifically sound measures standardized to reduce patient and provider burden while supporting care; and (c) engage providers using a stepwise approach that offers resources and incentives to support implementation. |
format | Online Article Text |
id | pubmed-10394208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103942082023-08-03 Improving patient-reported measures in oncology: a payer call to action Schmidt, Theresa Valuck, Tom Perkins, Brittany Riposo, Jacqlyn Patel, Palak Westrich, Kimberly Basch, Ethan McClellan, Mark J Manag Care Spec Pharm Viewpoints Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes the landscape of oncology PRMs and PR-PMs, identifies implementation barriers, and recommends solutions for public and private payers to accelerate the appropriate use of PRMs in oncology VBP programs. Our research used a multimethod approach that included a literature review, landscape scan, stakeholder interviews and survey, and a multistakeholder roundtable. The literature review and landscape scan found that limited oncology-specific PR-PMs are available and some are already used in VBP programs. Diverse stakeholder perspectives provided insight into filling current gaps in measurement and removing implementation barriers, such as limited relevance of existing PRMs and PR-PMs for oncology; methodological challenges; patient burden and survey fatigue; and provider burden from resource constraints, competing priorities, and insufficient incentives. Key recommendations include: (a) identify or develop meaningful measures that fill gaps, engaging patients throughout measure and program development and evaluation; (b) design programs that include scientifically sound measures standardized to reduce patient and provider burden while supporting care; and (c) engage providers using a stepwise approach that offers resources and incentives to support implementation. Academy of Managed Care Pharmacy 2021-01 /pmc/articles/PMC10394208/ /pubmed/33103618 http://dx.doi.org/10.18553/jmcp.2020.20313 Text en Copyright © 2021, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Viewpoints Schmidt, Theresa Valuck, Tom Perkins, Brittany Riposo, Jacqlyn Patel, Palak Westrich, Kimberly Basch, Ethan McClellan, Mark Improving patient-reported measures in oncology: a payer call to action |
title | Improving patient-reported measures in oncology: a payer call to action |
title_full | Improving patient-reported measures in oncology: a payer call to action |
title_fullStr | Improving patient-reported measures in oncology: a payer call to action |
title_full_unstemmed | Improving patient-reported measures in oncology: a payer call to action |
title_short | Improving patient-reported measures in oncology: a payer call to action |
title_sort | improving patient-reported measures in oncology: a payer call to action |
topic | Viewpoints |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394208/ https://www.ncbi.nlm.nih.gov/pubmed/33103618 http://dx.doi.org/10.18553/jmcp.2020.20313 |
work_keys_str_mv | AT schmidttheresa improvingpatientreportedmeasuresinoncologyapayercalltoaction AT valucktom improvingpatientreportedmeasuresinoncologyapayercalltoaction AT perkinsbrittany improvingpatientreportedmeasuresinoncologyapayercalltoaction AT riposojacqlyn improvingpatientreportedmeasuresinoncologyapayercalltoaction AT patelpalak improvingpatientreportedmeasuresinoncologyapayercalltoaction AT westrichkimberly improvingpatientreportedmeasuresinoncologyapayercalltoaction AT baschethan improvingpatientreportedmeasuresinoncologyapayercalltoaction AT mcclellanmark improvingpatientreportedmeasuresinoncologyapayercalltoaction |